About Lercanidipine

Therapeutic Category

Antihypertensive

Dose Form

Status

In Pipeline

Available Regulatory Filing

CAS No

100427-26-7

Pharmacopoeia

Mechanism of Action

Lercanidipine is a calcium channel blocker that selectively inhibits L-type calcium channels in vascular smooth muscle. By preventing calcium influx, it induces vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure, making it effective in the treatment of hypertension.

Indication

Indicated for the treatment of essential hypertension.